SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The filing discloses the appointment of David R. Wells as Chief Financial Officer and Board member effective May 18, 2026, approved by unanimous written consent. While the section also covers Tariq Rahim's resignation from the Board and transition from CFO, the principal disclosed action centers on the appointment of a new CFO and director, which is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →The CEO distributed a Shareholder Letter disclosing preliminary, unaudited financial results for fiscal year ending March 31, 2026, including expected year-over-year reductions in net loss and Adjusted EBITDA loss.
View raw filing on EDGAR →The Shareholder Letter references an ongoing warrant exchange offer (pursuant to a Schedule TO filed January 23, 2026) and an ongoing bridge financing under Regulation D, both material to the company's capital structure and financing strategy.
View raw filing on EDGAR →Evolution Metals & Technologies Corp. disclosed quarterly or annual financial results for the period, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →The Company disclosed that it will not file its Q1 2026 Form 10-Q within the Rule 12b-25 extension period and anticipates receiving a notice of non-compliance from Nasdaq under Listing Rule 5250(c)(1) due to the late filing. While the Company expects a grace period to regain compliance, the anticipated non-compliance with continued listing rules creates delisting risk.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Arbor Realty Trust's May 20, 2026 annual meeting, covering four proposals: election of Class II directors (Kaufman, Lazar, Wilkens, Natalone), amendment to the 2024 Omnibus Stock Incentive Plan, ratification of Ernst & Young LLP as auditor, and approval of named executive officer compensation. The tabular presentation of voting results (For/Against/Abstain/Broker Non-Votes) is the hallmark of Item 5.07 disclosure and is material to investors assessing board composition and governance decisions.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final results of Bank of the James Financial Group's Annual Meeting of Shareholders held on May 19, 2026, including voting outcomes on three proposals: election of four Group Two directors, ratification of Elliott Davis, PLLC as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content of this filing, which is the textbook definition of shareholder vote results disclosure.
View raw filing on EDGAR →MVB Financial Corp. held its 28th Annual Meeting of Shareholders on May 19, 2026, with voting results on four proposals: director elections, say-on-pay advisory vote, stock plan amendment, and auditor ratification. All proposals passed with substantial majorities.
View raw filing on EDGAR →MVB Financial Corp. announced a quarterly cash dividend of $0.17 per share, representing a material disclosure of capital allocation to shareholders.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Five9's 2026 annual meeting held on May 20, 2026, covering five distinct matters: board declassification, removal of supermajority voting requirements, election of two directors, advisory vote on executive compensation, and ratification of KPMG LLP as auditor. The filing provides detailed voting tallies for each proposal, which is the hallmark of Item 5.07 disclosure and constitutes material information affecting corporate governance and investor rights.
View raw filing on EDGAR →The Company disclosed achievement of Milestone 1 under a Contingent Value Right Agreement, triggering a direct financial obligation to pay approximately $33.4 million ($0.50 per CVR) in cash within 20 business days. While this is a material cash obligation disclosed under Item 2.03, it does not fit cleanly into the more specific event categories (it is neither a covenant breach, debt issuance, nor a traditional financial obligation like a loan). The CVR payment obligation is a contingent consideration from a prior transaction, making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Healthcare Realty Trust's annual meeting held May 19, 2026. The filing reports voting outcomes on three proposals: election of six directors (with vote tallies for each nominee), ratification of Deloitte & Touche LLP as independent auditor (99.86% approval), and non-binding advisory approval of executive compensation (91.68% approval). All three proposals passed with substantial majorities, and the disclosure includes detailed vote counts and percentages as required by Item 5.07.
View raw filing on EDGAR →Travel & Leisure Co. entered into a material definitive agreement on May 20, 2026, to issue $900 million in senior secured notes due 2031. The proceeds are earmarked for redemption of existing debt and repayment of credit facilities, representing a material refinancing activity with significant capital structure implications.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on May 14, 2026, covering three matters: election of eight directors, advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the core content of Item 5.07 and constitutes a material event affecting investor understanding of corporate governance and management approval.
View raw filing on EDGAR →The filing discloses the appointment of four new directors to the Board effective April 1, 2026: Elyssa Jacob Campbell, James C. Jones, Anthony Porter, and David Mauer. The disclosure provides detailed background on each appointee's professional experience and qualifications. This is a material governance event affecting board composition at a public company.
View raw filing on EDGAR →Stockholders approved five proposals at the Annual Meeting of stockholders, including election of Class I directors (Travis J. Boone and Robert S. Ledford), a say-on-pay advisory vote, ratification of KPMG LLP as auditor, approval of a Certificate of Amendment to the Certificate of Incorporation, and approval of Amendment No. 2 to the 2022 Long-Term Incentive Plan. The meeting also resulted in the retirement of two directors (Amonett and Foran) and a reduction of the board from eight to six members.
View raw filing on EDGAR →Iridium Communications held its Annual Meeting of Stockholders on May 20, 2026, with shareholders voting on four proposals: election of eleven directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of the Amended and Restated 2015 Equity Incentive Plan. All proposals passed with disclosed voting tallies.
View raw filing on EDGAR →Stockholders approved an amended and restated equity incentive plan reserving approximately 42.9 million shares for issuance under stock options and other equity awards, representing a material increase in share reserve and significant changes to the executive compensation structure.
View raw filing on EDGAR →Mr. Doug Behrens resigned from the Board of Directors effective immediately on May 18, 2026, and also served on the Compensation Committee. This is a clear departure of a director, which is material to investors as it affects board composition and committee membership. The filing explicitly states the resignation was not due to disagreement with the Company.
View raw filing on EDGAR →Stablecoin Development Corp disclosed results of operations for the quarter ended March 31, 2026, including updated SKY holdings and accumulated staking rewards. The quarterly earnings release was furnished via press release on May 20, 2026.
View raw filing on EDGAR →Envirotech Vehicles, Inc. entered into a definitive merger agreement with Azio AI Corporation, whereby Merger Sub will merge into Azio AI in exchange for 100,000,000 shares of EVTV common stock. The transaction constitutes a material change of control of the registrant, with specified closing conditions, governance changes, and stockholder approval requirements.
View raw filing on EDGAR →The registrant disclosed material compensatory arrangements for three named executives (Jason Maddox, Elgin Tracy, and Phillip W. Oldridge) in connection with the merger, including annual base compensation, guaranteed car allowances, severance provisions, change-of-control equity grants (1.5M shares each), and recognition bonuses totaling $500,000 each for Maddox and Tracy and $125,000 for Oldridge.
View raw filing on EDGAR →The company extended the maturity date of its Series C Convertible Redeemable Preferred Stock by one year to February 28, 2028, following majority shareholder approval and formalization via Certificate of Amendment filed with the Texas Secretary of State. This modification to the preferred stock terms materially affects the capital structure and investor rights of preferred shareholders.
View raw filing on EDGAR →Ms. Elizabeth Magennis was appointed President of ConnectOne Bancorp at the annual reorganizational meeting, representing a promotion from Executive Vice President.
View raw filing on EDGAR →ConnectOne Bancorp held its Annual Meeting of Shareholders on May 19, 2026, with shareholders approving all four proposals: election of fifteen directors, approval of the 2026 Equity Incentive Plan, advisory approval of executive compensation, and ratification of independent auditors.
View raw filing on EDGAR →The filing discloses a shareholder letter from the CEO posted on May 20, 2026, providing "updates regarding the Company's business and business plans." The forward-looking statements reference material project financing, pipeline construction milestones, regulatory developments, and technology commercialization at ATEC and Cadiz Ranch. While the specific content of the letter is not provided in the Item 7.01 disclosure itself, the CEO's public communication of business updates and strategic plans constitutes a material disclosure under Regulation FD. This does not fit neatly into the more specific event categories (no earnings release, M&A, executive change, or financial restatement is indicated), making "other_material" the appropriate classification.
View raw filing on EDGAR →cbdMD entered into a Third Amendment to Lease on May 20, 2026, extending its warehouse and executive office facility lease by 62 months through November 2031 with a reduced footprint and materially lower rent, generating approximately $100,000–$120,000 in annual net rent expense reduction. The amendment creates a direct financial obligation under the extended lease terms and is operationally significant for the company's long-term occupancy and operating expenses.
View raw filing on EDGAR →Proto Labs held its Annual Meeting of Shareholders on May 19, 2026, with voting results disclosed on five proposals: election of seven directors, ratification of Ernst & Young LLP as auditor, advisory approval of executive compensation, frequency of future advisory votes on compensation, and approval of an amendment to the 2022 Long-Term Incentive Plan increasing the equity award pool by 395,000 shares.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Altisource's 2026 Annual General Meeting of Shareholders held on May 20, 2026, with detailed voting tallies for eight proposals including director elections, auditor appointments, financial statement approvals, executive compensation (Say-on-Pay), and equity plan amendments. The disclosure of shareholder vote results at an annual meeting is the textbook definition of shareholder_vote_results, and the outcomes are material to investors as they confirm board composition, auditor selection, and compensation/equity plan approvals.
View raw filing on EDGAR →Mannix Aklian ceased his role as Chief Commercial Officer, Global Head of Software Sales and Marketing, effective immediately. Paul Davie returned as interim Chief Commercial Officer.
View raw filing on EDGAR →The filing discloses that Nasdaq notified the Company on May 14, 2026 of its determination to delist the Company's common stock pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company's Chapter 11 bankruptcy filing. Trading will be suspended on May 21, 2026, and a Form 25-NSE will be filed to remove the Common Stock from listing and registration on Nasdaq. This is a material delisting event that directly affects the registrant's public market access.
View raw filing on EDGAR →Brand Engagement Network Inc. disclosed the grant of U.S. Patent No. 12,633,027 titled "Systems and Methods for Gesture Generation From Text" to its subsidiary Datum Point Labs on May 19, 2026. The company describes this as supporting its core AI technology capability for generating lifelike gestures from avatars and enabling real-time user interaction. While the filing does not fit neatly into standard 8-K event categories (earnings, M&A, executive changes, etc.), a material patent grant for a technology-dependent company's core product functionality would reasonably affect an investor's assessment of the registrant's competitive position and intellectual property portfolio, warranting disclosure as a material event under Item 8.01.
View raw filing on EDGAR →Item 1.01 discloses entry into a Membership Interests Purchase Agreement on May 19, 2026, whereby Soluna Digital, Inc. acquired 49% of the Dorothy 1B Project Company (a bitcoin mining entity) from Navitas West Texas Investments SPV, LLC for approximately $8.8 million, with closing occurring simultaneously. The filing explicitly states that upon closing, the Purchaser owns 100% of the membership interests, indicating a material acquisition of equity interests in an operating subsidiary focused on bitcoin mining operations.
View raw filing on EDGAR →Telomir Pharmaceuticals disclosed publication of a peer-reviewed preclinical study on its lead candidate Telomir-1 in Wilson's disease, demonstrating positive efficacy signals including reductions in oxidative stress, hepatic copper accumulation, and improvements in survival outcomes. While this is a positive development for a clinical-stage biotech company, it does not fit neatly into the standard 8-K taxonomy—it is neither an earnings release (no financial results), nor an executive change, M&A activity, or other discrete event type. The disclosure is material to investors evaluating the company's pipeline prospects, warranting classification as other_material.
View raw filing on EDGAR →The filing discloses the appointment of Gregg Hemphill as a director of Newton Golf Company, Inc., effective May 19, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The Board also appointed him to serve on three committees (Audit, Compensation, and Nominating). While the disclosure includes compensation details (annual cash retainer of $30,000 and RSU grants), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →Jupiter Neurosciences entered into a non-binding Term Sheet with PharmAla Biotech on May 19, 2026, regarding a potential licensing transaction to acquire exclusive U.S. rights to ALA-002, a proprietary MDMA formulation, along with related intellectual property and regulatory materials. The transaction contemplates $3.3M upfront consideration plus substantial development and commercialization milestones up to $63.3M, plus perpetual 3% royalties. While the Term Sheet is explicitly non-binding and contingent on definitive agreements within 90 days, the disclosure of a material acquisition of a drug program with defined consideration and milestone structure constitutes a reportable M&A activity under Item 8.01 and Item 7.01.
View raw filing on EDGAR →Adam Desmond resigned effective May 14, 2026 from all positions including CEO and CFO, with a Separation Agreement filed as Exhibit 10.1. While the filing also discloses the appointment of Krystal Eckhart as Interim CEO and CFO on May 15, 2026, the principal disclosed event centers on the departure of the CEO/CFO. The departure of a chief executive officer is material to investors assessing company leadership and continuity.
View raw filing on EDGAR →Item 2.02 discloses that on May 15, 2026, SurgePays issued a press release announcing financial results for the quarter ended March 31, 2026, with a conference call to discuss those results. The press release is furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.
View raw filing on EDGAR →The filing discloses that on May 19, 2026, Aimei Health Technology received a notice from Nasdaq's Listing Qualifications Department stating the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for the quarter ended March 31, 2026. The notice explicitly states that if the Company fails to regain compliance, "the Company's securities will be subject to delisting from Nasdaq." This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Mike Sayama, an independent director, notified the Company on May 14, 2026 that he would not seek re-election at the 2026 Annual Meeting of Stockholders. The board has reduced its size from five to four members effective immediately prior to the AGM. While framed as a non-reelection rather than a resignation, this constitutes a departure of a director from the board, which is material to investors assessing board composition and governance. The filing explicitly states the departure was not due to disagreement, suggesting a routine transition, but the event itself—loss of an independent director—is material.
View raw filing on EDGAR →The filing discloses the termination of two C-suite executives: Anson Neo (CEO) and Tan Yee Siong (CFO), both effective May 17, 2026, determined to be terminations for cause. While the filing also includes appointments of replacement executives (Tjin Patrick Soetanto as CEO and Wallace Tzi Chun Foo as CFO) and a director change, the primary and most salient event is the departure of the CEO and CFO, which materially affects investor assessment of management continuity and company operations.
View raw filing on EDGAR →The filing discloses entry into a sales agreement with Aegis Capital Corp. for an "at the market" offering program under which the Company may sell up to $60.0 million of common stock shares. This is a dilutive equity issuance under Item 1.01, structured as an ATM offering pursuant to Rule 415(a)(4) under the Securities Act of 1933. The magnitude ($60 million) and nature of the offering (unregistered equity sales to raise capital) are material to investors' assessment of share dilution and the registrant's capital structure.
View raw filing on EDGAR →Item 2.02 discloses that DNA X, Inc. issued a press release on May 20, 2026 announcing financial results for the fiscal quarter ended March 31, 2026, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.
View raw filing on EDGAR →The filing discloses that the U.S. Nuclear Regulatory Commission has formally accepted Nano Nuclear Energy's Construction Permit Application for deployment of its KRONOS MMR™ at the University of Illinois Urbana-Champaign. This is a significant regulatory milestone for a nuclear technology company, indicating progress toward commercialization of a key product. While this does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, executive change, or other enumerated categories), it is material to investors as it represents a major regulatory approval that affects the company's ability to execute its business plan.
View raw filing on EDGAR →Item 3.02 discloses an unregistered sale of equity securities completed on May 19, 2026, consisting of bonds and 16 warrants yielding approximately $56 million in gross proceeds. The warrants entitle holders to purchase 2,603,936 shares of common stock at an exercise price of NIS 39.8 (approximately $13.69), creating significant dilution potential. This is a classic dilutive issuance under Regulation S, with the underlying shares to be registered on Form S-3.
View raw filing on EDGAR →This Item 5.07 filing discloses the complete voting results from Bankwell Financial Group's Annual Meeting of Shareholders held on May 20, 2026, including election of ten directors, advisory votes on executive compensation and frequency thereof, and ratification of independent auditors. All proposals passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors as it confirms governance outcomes.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Sprout Social's 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports final voting tallies for three proposals: election of two Class I directors (Peter Barris and Karen Walker), ratification of PricewaterhouseCoopers LLP as independent auditor, and an advisory vote on named executive officer compensation. All three proposals passed. This is material as it documents the formal outcomes of stockholder actions on governance and audit matters.
View raw filing on EDGAR →The Company determined that interest on its 7.00% Subordinated Convertible Notes due 2031 will be paid in Series D Cumulative Convertible Preferred Stock rather than cash on the June 30, 2026 payment date. This represents a material change in the form of debt service that signals potential liquidity constraints and affects the economic terms of the convertible notes for investors, but does not fit neatly into the more specific event categories (not a covenant breach, restatement, or going-concern disclosure, though it may be a precursor to such events).
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Alkami Technology's 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents voting results for three proposals: election of three Class II directors (all elected), ratification of Ernst & Young LLP as independent auditor (ratified), and advisory approval of named executive officer compensation (approved). The detailed vote tallies and outcomes are the core content of this 8-K section.
View raw filing on EDGAR →The filing discloses a change in special servicer for the Bravern Office Commons mortgage loan securitization, with Torchlight Loan Services replacing KeyBank National Association effective May 20, 2026. While this is an administrative change in loan servicing roles, it involves a material securitized asset and could signal concerns about loan performance or servicer capability. However, it does not fit cleanly into the standard taxonomy categories (not an M&A activity, covenant breach, or impairment), warranting classification as other_material.
View raw filing on EDGAR →